Research Article
Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease
Table 7
Risk factors of metabolic syndrome in subjects with non-fatty liver disease by multivariate analysis.
| | Odds ratio | 95% confidence interval | P value |
| All subjects | | | | BMI | 1.371 | 1.346–1.397 | <0.001 | Age | 1.042 | 1.038–1.046 | <0.001 | ALT | 1.007 | 1.004–1.010 | <0.001 | GGT | 1.004 | 1.002–1.006 | <0.001 | Platelet | 1.001 | 1.001–1.002 | 0.001 | Male gender | 4.071 | 3.628–4.568 | <0.001 | Female subjects | | | | BMI | 1.382 | 1.339–1.426 | <0.001 | Age | 1.080 | 1.070–1.089 | <0.001 | ALT | 1.010 | 1.005–1.015 | <0.001 | Platelet | 1.002 | 1.000–1.003 | 0.028 | Male subjects | | | | BMI | 1.351 | 1.320–1.383 | <0.001 | Age | 1.032 | 1.028–1.037 | <0.001 | ALT | 1.005 | 1.001–1.009 | 0.021 | GGT | 1.005 | 1.003–1.007 | <0.001 | Platelet | 1.002 | 1.001–1.003 | 0.002 |
|
|
BMI, body mass index; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase.
|